Previous Article
Infection and Immunity, December 1998, p. 6063-6064, Vol. 66, No. 12
0019-9567/98/$00.00+0
LETTERS TO THE EDITOR
Reflux in the Mouse Model of Urinary Tract Infection
 |
LETTER |
Two studies recently published in Infection and
Immunity involved a mouse model of ascending urinary tract
infection (UTI) (1, 6). The inoculation conditions used in
both studies, i.e., 20 to 50 µl of bacterial suspension inoculated
into the bladder, had been found in a previous study from the same
laboratory to produce immediate vesicoureteral reflux (VUR) in a
substantial proportion of mice (2).
As recognized by these and other investigators, VUR should be avoided
in the mouse model of UTI because it introduces bacteria directly into
the upper urinary tract, thereby bypassing important proximal steps in
pathogenesis (but in an uncontrolled fashion), and because it can cause
hydrostatic injury to the renal parenchyma, thereby rendering the model
unrepresentative of uncomplicated ascending UTI in humans (2,
3). The investigators' previous study, in which VUR could be
avoided only by reduction of the inoculum volume to 10 µl and
inoculation into the urethra rather than the bladder (2),
was cited for the methods used in the recent studies despite the use of
larger volumes and inoculation into the bladder in the recent studies
(1, 6).
High levels of kidney infection were observed in the recent studies
(1, 6), whereas negligible levels were achieved in the
investigators' previous study with the same bacterial strain (strain
1677) when VUR-free inoculation conditions were used (2). This finding suggests that inoculation-induced VUR may have accounted for some or most of the kidney infections encountered in the recent studies, a possibility which calls into question the physiological relevance of the studies' findings. Interpretation of results thus
would be aided by knowledge of whether experiments were done to confirm
that the inoculation conditions used did not induce immediate VUR. In
addition, since others have documented that 25 to 50 µl can be
inoculated into the mouse bladder without causing VUR (4,
5), whereas Hopkins et al. previously found this not to be
the case (2), it would be of considerable value to current
or future users of the mouse model to know what VUR-avoidance measures
Hopkins et al. may have introduced since their previous study
(2).
 |
REFERENCES |
| 1.
|
Hopkins, W. J.,
A. Gendron-Fitzpatrick,
E. Balish, and D. T. Uehling.
1998.
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
Infect. Immun.
66:2798-2802[Abstract/Free Full Text].
|
| 2.
|
Hopkins, W. J.,
J. A. Hall,
B. P. Conway, and D. T. Uehling.
1995.
Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model.
J. Infect. Dis.
171:462-465[Medline].
|
| 3.
|
Johnson, J. R., and J. C. Manivel.
1991.
Vesicoureteral reflux induces renal trauma in a mouse model of ascending, unobstructed pyelonephritis.
J. Urol.
145:1306-1311[Medline].
|
| 4.
|
Johnson, J. R., and J. J. Brown.
1996.
Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection.
J. Infect. Dis.
173:746-749[Medline].
|
| 5.
|
Mobley, H. L. T.,
K. G. Jarvis,
J. P. Elwood,
D. I. Whittle,
C. V. Lockatell,
R. G. Rusell,
D. E. Johnson,
M. S. Donnenberg, and J. W. Warren.
1993.
Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of Gal(1-4) Gal binding in virulence of a wild-type strain.
Mol. Microbiol.
10:143-155[Medline].
|
| 6.
|
Morin, M. D., and W. J. Hopkins.
1998.
Treatment of mice with staphylococcal enterotoxin B enhances resolution of an induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines.
Infect. Immun.
66:2466-2470[Abstract/Free Full Text].
|
| | | | |
James R. Johnson
Infectious Diseases (111F) Minneapolis VA Medical Center 1 Veterans Drive Minneapolis, Minnesota 55417
|
 |
AUTHOR'S REPLY |
My colleagues and I appreciate the observations and comments of Dr.
Johnson regarding two recent articles on susceptibility and resistance
of mice to an induced Escherichia coli urinary tract
infection (UTI) (2, 3). Of particular interest were the
inoculation procedures used in these studies and the effect of
inoculation on development of kidney infections.
The objectives of the first study (1) were to demonstrate
possible differences in the susceptibility and immune responses of
different inbred mouse strains to an induced E. coli UTI.
These experiments examined the UTI resolution patterns and host
inflammatory and antibody-forming cell responses of 10 mouse strains
inoculated with the same bacterial strain and were conducted over an
extended period of time. During the course of these and other studies
(3) of induced UTIs in mice, we examined the effects of
inoculum volume and route on vesicoureteral reflux and induction of
kidney infections. Our results indicated that large inoculum volumes
delivered into the bladder increased the incidence of kidney
infections. A majority of the 10 mouse strains in the
susceptibility/host response study had been screened by using a 50-µl
bladder inoculum prior to our examination of inoculation conditions.
Consequently, the remaining mice were also inoculated with a 50-µl
volume to maintain consistency. It is thus possible that kidney
infections observed in some mouse strains could be attributed to
inoculation-associated reflux. It is important to note, however, that
even under these conditions, not all mouse strains developed kidney
infections and there were differences in severity among strains both
early and late in the course of infection. We also noted that
inflammatory and splenic antibody-forming cell responses were
positively correlated with kidney infection intensity and believe this
would be the case regardless of how the kidney infections were induced.
The objective of the second study (4) was to examine the
effect of superantigen exposure on the resolution of bladder infection and induction of cytokines. Mice in these experiments were inoculated with E. coli instilled into the bladder in a 20-µl volume.
We did not evaluate kidney infections in these mice and, therefore, do
not have information on infection intensities or cytokine production in
the kidneys. The reported effects of staphylococcal enterotoxin B on
bladder infection resolution and cytokine induction are not likely to
be affected by inoculation conditions.
 |
REFERENCES |
| 1.
|
Hopkins, W. J.,
A. Gendron-Fitzpatrick,
E. Balish, and D. T. Uehling.
1998.
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
Infect. Immun.
66:2798-2802.
|
| 2.
|
Hopkins, W. J.,
J. A. Hall,
B. P. Conway, and D. T. Uehling.
1995.
Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model.
J. Infect. Dis.
171:462-465.
|
| 3.
|
Morin, M. D., and W. J. Hopkins.
1998.
Treatment of mice with staphylococcal enterotoxin B enhanced resolution of induced Escherichia coli urinary tract infection and stimulates production of proinflammatory cytokines.
Infect. Immun.
66:2466-2470.
|
| | | | |
Walter J. Hopkins
Department of Surgery University of Wisconsin Madison 600 Highland Avenue Madison, Wisconsin 53792
|
Infection and Immunity, December 1998, p. 6063-6064, Vol. 66, No. 12
0019-9567/98/$00.00+0
This article has been cited by other articles:
-
Lane, M. C., Alteri, C. J., Smith, S. N., Mobley, H. L. T.
(2007). Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. USA
104: 16669-16674
[Abstract]
[Full Text]
-
Asahara, T., Nomoto, K., Watanuki, M., Yokokura, T.
(2001). Antimicrobial Activity of Intraurethrally Administered Probiotic Lactobacillus casei in a Murine Model of Escherichia coli Urinary Tract Infection. Antimicrob. Agents Chemother.
45: 1751-1760
[Abstract]
[Full Text]